glucagon has been researched along with ono 3708 in 2 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (ono 3708) | Trials (ono 3708) | Recent Studies (post-2010) (ono 3708) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 101 | 5 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haba, Y; Hanazaki, K; Kuroda, T; Shiohara, E | 1 |
| Haba, Y; Kuroda, T | 1 |
2 other study(ies) available for glucagon and ono 3708
| Article | Year |
|---|---|
The effect of a thromboxane A2 receptor antagonist (ONO 3708) on ischemia-reperfusion injury of the dog pancreas.
Topics: Amylases; Animals; Dogs; Epoprostenol; Female; Glucagon; Insulin; Lipid Peroxides; Male; Pancreas; Receptors, Thromboxane; Reperfusion Injury; Sincalide; Thromboxane A2 | 1994 |
Thromboxane A2 receptor antagonist (ONO 3708) protects from liver damage induced by cholestasis and ischemia-reperfusion.
Topics: Animals; Cholestasis; Dogs; Glucagon; Glutathione; Insulin; Lipid Peroxides; Liver; Liver Circulation; Receptors, Thromboxane; Reperfusion Injury; Thromboxane A2; Vitamin E | 1995 |